WST - Company ID 0000105770
WEST PHARMACEUTICAL SERVICES INC trades as WST and has a market capitalization of $25.27 B, making it the #538 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $3.07B, up 6.3% from the prior year and net income of $493.70M. This page tracks WEST PHARMACEUTICAL SERVICES INC through 3,429 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years WEST PHARMACEUTICAL SERVICES INC's revenue grew from $1.51B to $3.07B, a compound annual growth rate of 8.2%. Net profit margin expanded from 12.0% to 16.1% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event (amended) | 8-K/A | 2026-05-20 |
| Insider trade | 4 | 2026-05-14 |
| SD | - | 2026-05-13 |
| Major company event | 8-K | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-07 |
| Insider trade | 4 | 2026-05-06 |
| Insider trade | 4 | 2026-05-06 |
| Insider trade | 4 | 2026-05-06 |
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
Daikyo Crystal Zenith® Polymer Ready-to-Use Syringe Systems
The largest companies sharing WEST PHARMACEUTICAL SERVICES INC's SEC industry classification (surgical & medical instruments & apparatus).
WEST PHARMACEUTICAL SERVICES INC (WST) has a market capitalization of $25.27 B as of 2026-07-09, ranking #538 among US-listed companies.
WEST PHARMACEUTICAL SERVICES INC reported revenue of $3.07B for fiscal year 2025, an increase of 6.3% year over year.
Yes. WEST PHARMACEUTICAL SERVICES INC reported net income of $493.70M in its latest fiscal year.